Flucloxacillin sodium BP PRESENTATION Flustar® 250 Capsule: Each capsule contains Flucloxacillin sodium BP equivalent to 250mg Flucloxacillin. Flustar® 500 Capsule: Each capsule contains Flucloxacillin sodium BP equivalent to 500mg Flucloxacillin. Flustar® Dry Powder for Suspension: After reconstitution, each 5ml contains Flucloxacillin sodium BP equivalent to 125mg Flucloxacillin. INDICATIONS Flustar® is indicated for the treatment of infections due to Gram-positive organisms, including infections caused by beta-lactamase producing Staphylococci. Typical indications include: Skin and soft tissue infections: Boils, abscesses, carbuncles, infected skin conditions- for example, ulcer, eczema and acne. Furunculosis, cellulitis, infected wounds, infected bums, protection for skin grafts, otitis media and external impetigo. Respiratory tract infections: Pneumonia, lung abscess, empyema, sinusitis, pharyngitis, tonsillitis, quinsy. Other infections caused by Flustar® sensitive organisms: Osteomyelitis, enteritis, endocarditis, urinary tract infections, meningitis, septicemia. DOSAGE AND ADMINISTRATION Should be administered half to one hour before meals. Usual adult dosage (including elderly patients): 250mg four times daily. In severe infections: Dosage should be doubled. In osteomyelitis, endocarditis: Upto 8g daily in divided doses 6 to 8 hourly. In case of secondary bacterial infection in chicken pox: Flustar® 500mg 6 hourly. Usual child dosage: 2-10 years: Half of the adult dosage. Under 2 years: Quarter of the adult dosage. Children have been given doses of 12.5 to 25mg per kg body weight 4 times daily. Dose adjustment in renal impairment: In common with other penicillins, Flustar® usage in patients with renal impairment does not usually require dosage reduction. However, in the presence of severe renal failure (creatinine clearance <10 ml/min) a reduction in dose or an extension of dose interval should be considered. Flustar® is not significantly removed by dialysis and hence no supplementary dosages need to be administered either during or at the end of the dialysis period. CONTRAINDICATIONS Penicillin hypersensitivity, ocular administration. USE IN PREGNANCY AND LACTATION Animal studies with Flucloxacillin have shown no teratogenic effects. The use of Flucloxacillin in pregnancy should be reserved for cases considered essential by the clinician. During lactation, trace quantities of penicillins can be detected in breast milk. SIDE EFFECTS Side effects, as with other penicillins, are uncommon and mainly of a mild and transitory nature, gastrointestinal upsets (e.g. nausea, diarrhoea) and skin rashes have been reported. If skin rash occurs, treatment should be discontinued. DRUG INTERACTIONS The administration of probenecid with Flucloxacillin results in higher serum peak concentrations and prolong the time that therapeutic concentrations of Flucloxacillin are achieved in serum. Physical incompatibility and/or loss of activity of Flucloxacillin in solution has been reported when given with gentamycin sulphate, streptomycin sulphate, vitamin mixtures. OVERDOSAGE Problems of overdosage with Flucloxacillin are unlikely to occur; if encountered they may be treated symptomatically. PHARMACEUTICAL PRECAUTIONS Store in a cool & dry place, protected from light. Flustar® Dry Powder for Suspension should be freshly prepared. Prepared suspension is to be consumed within 7 days of preparation if kept in room temperature or within 14 days if kept in a refrigerator. PACKAGING Flustar 250mg Capsule: Box containing 12X4 capsules in alu-alu blisters. Flustar 500mg Capsule: Box containing 7X4 capsules in alu-alu blisters. Flustar Dry Powder for Suspension: Dry powder in glass bottle for reconstitution into 100ml of suspension. Renata Limited Rajendrapur, Gazipur Bangladesh ® Trade Mark
© Copyright 2024